Patents Examined by Trevor Kane
  • Patent number: 11959122
    Abstract: A method for assessing microbial drug resistance multi-level risks of antibiotic residues in water environments, belonging to the technical field of water environment assessment, comprises the following steps: S1, environment monitoring; S2, preliminary screening of antibiotics: S2-1, determination of n-octanol/water partition coefficient, and S2-2, determination of antibiotic environment concentration; S3, assessment of microbial drug resistance; and S4, high-level assessment. The assessment method of the present disclosure conducts a step-by-step assessment of target antibiotics or target antibiotic derivatives in water environment with risks.
    Type: Grant
    Filed: May 27, 2023
    Date of Patent: April 16, 2024
    Assignees: NANJING INSTITUTE OF ENVIRONMENTAL SCIENCES, MEE, NANJING UNIVERSITY
    Inventors: Xinyan Guo, Na Wang, Qingbin Yuan, Ni Ni, Xiaohui Zhang, Mali Shi, Jingbiao Li
  • Patent number: 11946093
    Abstract: A method and modified fermentation intermediate are disclosed for the production of polyunsaturated fatty acid (PUFA). The method comprises heat sterilizing a fermentation medium comprising dextrose to produce a heat sterilized fermentation medium, wherein the heat sterilizing converts at least a portion of the dextrose to DP2+ sugars. The method comprises combining the heat sterilized fermentation medium with an enzyme capable of converting DP2+ sugars to dextrose, thereby producing a modified heat sterilized fermentation medium comprising more dextrose and less DP+ 2 sugars than without combining the medium with the enzyme. The modified heat sterilized fermentation intermediate may be placed in contact with a microorganism to produce PUFA, wherein the microorganism is capable of utilizing dextrose to produce PUFA.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: April 2, 2024
    Assignee: ARCHER-DANIELS-MIDLAND COMPANY
    Inventor: Jill M. Morriss
  • Patent number: 11932891
    Abstract: The subject invention provides microbe-based products and efficient methods of producing them. In specific embodiments, methods are provided for enhanced production of microbial biosurfactants, the methods comprising co-cultivating Myxococcus xanthus and Bacillusamyloliquefaciens. In preferred embodiments, co-cultivation is carried out continuously for an indefinite period of time. Microbe-based products produced according to the subject methods are also provided, as well as their uses in, for example, agriculture, oil and gas recovery, and health care.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: March 19, 2024
    Assignee: LOCUS SOLUTIONS IPCO, LLC
    Inventors: Sean Farmer, Ken Alibek, Yajie Chen
  • Patent number: 11905542
    Abstract: The present invention is related to a novel enzymatic process for production of retinyl esters, such as in particular retinyl long chain esters, via conversion of retinol, which process includes the use of enzymes having acyltransferase activity. Said process might be used for biotechnological production of vitamin A.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: February 20, 2024
    Assignee: DSM IP ASSETS B.V.
    Inventors: Nathalie Balch, Paul Blomquist, Reed Doten, Peter Houston, Ethan Lam, Jenna McMahon, Joshua Trueheart, Celine Viarouge
  • Patent number: 11897831
    Abstract: Disclosed are a pregabalin artificial hapten, artificial antigen and preparation method therefor and application thereof. The structure of the pregabalin artificial hapten is shown as formula (I) and structure of the pregabalin artificial antigen is shown as formula (II). The application is in the preparation for anti-pregabalin antibodies with the pregabalin artificial antigen. The pregabalin artificial hapten retains the characteristic structure of pregabalin to the greatest extent, and has an active group that can be coupled with a carrier protein, and can be used as an antigenic determinant; the pregabalin artificial antigen obtained by further preparation can immune to obtain anti-pregabalin antibodies with high affinity, high sensitivity and strong specificity. The titer of the immune serum obtained by immunizing New Zealand white rabbits is as high as 1:90000, which can be used for rapid and accurate immunoassay of pregabalin.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: February 13, 2024
    Assignee: HANGZHOU TONGZHOU BIOTECHNOLOGY CO., LTD.
    Inventors: Yueshui Shao, Zhen Wang
  • Patent number: 11898139
    Abstract: Provided herein is a culturing method for bacteria of the genus Rhizobium whereby a low viscosity can be maintained in a culture solution during the culturing of and at the end of culturing of said bacteria, and that enables easy and efficient post-procedures, including concentration and separation of viable bacteria, among others. This is achieved by growing Rhizobium bacteria by liquid culture using a medium containing a disaccharide (for example, maltose, trehalose, lactose, sucrose) accounting for at least 25 mass % of the carbon source in the medium while maintaining a pH of 5.0 to 7.0 in the culture solution throughout the course of the culture, namely from the beginning of the culturing to the end of the culturing of said bacteria.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: February 13, 2024
    Assignees: Kumiai Chemical Industry Co., Ltd., K.I Chemical Industry Co., Ltd., Okayama Prefectural Government
    Inventors: Toshinobu Yamazaki, Shingo Hattori, Tatsuya Horiuchi
  • Patent number: 11898189
    Abstract: A microalgal strain of the species Nannochloropsis gaditana is characterized by a mutation of an enzyme involved in the biosynthesis of chlorophyll that changes the physiology thereof with respect to the wild-type strain of the same species. In particular, with the mutation, microalgae are formed which, with respect to the wild-type strain of the same species, have a lower chlorophyll content and a reduced capacity to absorb visible radiation (light). Further, a process for the production of lipids through the cultivation of the mutated Nannochloropsis gaditana strain and the lipids obtained can be used as synthesis intermediates, particularly in the so-called “green-chemistry” sector or in the production of biofuels.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: February 13, 2024
    Assignee: ENI S.P.A.
    Inventors: Roberta Miglio, Tomas Morosinotto, Alessandra Bellan
  • Patent number: 11891640
    Abstract: The present disclosure relates to terpene synthases capable of producing terpenoids. In one instance, a transformed organism can include terpene synthases or vectors encoding such synthases. One method of employing such synthases and organisms includes protecting an algal culture, in which the produced terpenoid can act as a biocide.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: February 6, 2024
    Assignee: National Technology & Engineering Solutions of Sandia, LLC
    Inventors: Ryan Wesley Davis, Tyler Phillips Eckles, Nataly Lyn Beck, Oliver Kilian
  • Patent number: 11859218
    Abstract: The invention involves the provision of recombinant algal mutants that have a genetic modification to a nucleic acid sequence encoding a trehalose biosynthetic enzyme, and/or a genetic modification to a nucleic acid encoding an RNA binding domain. And in some embodiments either of these algal mutants can further have a genetic mutation to a nucleic acid sequence encoding an SGI1 polypeptide. Attenuation of one, two, or all three of these genes results in a mutant organism with increased lipid productivity. It was also discovered that one, two, three, or more genetic mutations can be accumulated or “stacked” in a particular mutant cell or organism to result in further increases in the production of lipid products. The lipid products of these mutants are useful as biofuels or for other specialty chemical products.
    Type: Grant
    Filed: December 16, 2020
    Date of Patent: January 2, 2024
    Assignee: Viridos, Inc.
    Inventors: Eric R. Moellering, Saheed Imam, Luke Peach, Ryan Kalb, Sarah Potts
  • Patent number: 11835522
    Abstract: In some aspects, the disclosure relates to compositions and method for detection, classification, and treatment of cancer. In some embodiments, the disclosure relates to protease imaging sensors comprising a scaffold linked to an enzyme-specific substrate that includes a first detectable marker capable of being released from the prostate protease sensor when exposed to an enzyme present in cancer and a tumor imaging agent comprising a second detectable marker that is linked to the scaffold. In some embodiments, the disclosure relates to methods of monitor progression of a tumor in a subject based upon detection of detectable markers in a sample obtained from a subject who has been administered a protease imaging sensor, upon detection of a tumor imaging agent, or any combination thereof.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: December 5, 2023
    Assignee: Massachusetts Institute of Technology
    Inventors: Sangeeta N. Bhatia, Liangliang Hao
  • Patent number: 11814663
    Abstract: The present invention concerns a new mutant strain of Clostridium acetobutylicum comprising attenuated glycerol kinase activity. In addition, the present invention concerns a consortium of Clostridium comprising at least said mutant strain and at least one other species of Clostridium chosen among C. sporogenes and C. sphenoides. As this modified strain may be adapted for growth and for the production of 1,3-propanediol in an appropriate culture medium with high glycerol content, the invention also relates to a method for the production of 1,3-propanediolandbutyric acid, by culturing at least this mutant strain in an appropriate culture medium.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: November 14, 2023
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Céline Raynaud, Laurence Dumon-Seignovert, Nadège Dumoulin
  • Patent number: 11802819
    Abstract: The invention relates to a method for sample preparation on a spectrometric sample support, comprising the steps of: (i) providing the sample support with an arrangement of individual liquid droplets, for example of washing liquid or nutrient solution, each of which has microorganism sediments enclosed in it; (ii) locating a plate of an absorbent material containing cotton fibers, for example, above the sample support; (iii) lowering the plate vertically onto the sample support in such a way that microorganism sediments and plate come into contact, whereby the droplets of liquid are absorbed into the absorbent material; (iv) lifting the plate, which is locally enriched with droplet liquid, off the sample support, thereby exposing the microorganism sediments that are depleted of liquid; and (v) preparing the exposed microorganism sediments for spectrometric measurement, by means of infrared spectrometry or MALDI time-of-flight mass spectrometry, for example.
    Type: Grant
    Filed: January 14, 2020
    Date of Patent: October 31, 2023
    Inventor: Alexander Vossgröne
  • Patent number: 11767545
    Abstract: A microorganism having at least one SPX gene encoding SPX protein responsive to phosphorus deficiency, and characterized in that a function of the SPX protein is decreased or lost by introducing gene mutation into the SPX gene.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: September 26, 2023
    Assignees: HIROSHIMA UNIVERSITY, TOKYO INSTITUTE OF TECHNOLOGY, MAZDA MOTOR CORPORATION
    Inventors: Atsushi Sakamoto, Kumiko Okazaki, Takashi Yamamoto, Hiroyuki Ohta, Koichi Hori, Shinsuke Shimizu, Akihide Takami, Seiji Nomura, Fumihiko Saito